Locations:
Search IconSearch
May 24, 2022/Neurosciences/PM&R

High-Intensity Home-Based Rehab: AHRQ Grant Helps Size Up Its Utility for Stroke Patients

Novel post-acute care model aims to improve functional outcomes with reduced costs

22-NEU-2922371-CQD-Hero-650×450

An innovative approach to deliver rehabilitation therapy at home instead of in specialized care facilities for patients following a stroke is getting a boost with a five-year Agency for Healthcare Research and Quality K01 grant to evaluate its effectiveness.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Developed by a multidisciplinary team at Cleveland Clinic, the “Home Care Plus” program, a model of high-intensity home-based rehabilitation (HIHR), includes physical and occupational therapy, nursing services and custodial services provided by aides from a contracted private agency. A previous pilot study in a broader group of post-acute care patients showed that outcomes compared favorably to those achieved during a 14-day stay in a skilled nursing facility.

Focusing in on stroke

The Home Care Plus model for patients with stroke is the result of efforts of an interdisciplinary team that has worked on its design and implementation since 2020, including the following Cleveland Clinic health system leaders: Dolora Wisco, MD, of the Neurological Institute; William Zafirau, MD, and Steven Pamer, PT, MPA, of the Center for Connected Care; Karen Green, DPT, of Rehabilitation and Sports Therapy; and Jessica Hohman, MD, MSc, of the Medicare Accountable Care Organization.

“We have narrowed the focus to stroke patients for the current project because rehabilitation is an evidence-based part of their care,” explains grant recipient Joshua Johnson, DPT, PhD, Director of Outcomes Research in Cleveland Clinic’s Department of Physical Medicine and Rehabilitation. “Discharge to an acute rehabilitation facility is typical, but most of these individuals would prefer a home-based program. With this study, we’re evaluating what is already being done within our health system to address that goal.”

Since the program’s implementation in October 2021, 23 stroke patients have been treated by Cleveland Clinic Home Care using the HIHR model, and Dr. Johnson says the initial results have been positive. “There have been no red flags, and we’re finding that patients are making pretty significant functional gains over the course of the care episode, based on the CARE Tool Section GG scores now required by Medicare,” he notes.

Advertisement

Stroke patients are eligible for HIHR if they have mild to moderate functional impairment, mild to moderate stroke-related symptoms, stable medical status, minimal skilled nursing needs and at least some caregiver support at home. The focus in HIHR is increasing therapy service intensity. Patients receive as many as 12 visits a week from rehabilitation professionals, versus the one to three that are typical for home care.

“Our goal is for the therapists, primarily, to be in the home more often so they can meet the needs they observe for these patients and their families,” Dr. Johnson says. “We are working to tailor care to the patient. If a patient’s main deficits pertain to speech, then a speech therapist is their primary provider, not an occupational or physical therapist.”

Of the 58 patients who completed the HIHR pilot program, which was rolled out in 2019, 97% improved in measures of functional independence. The average cost per HIHR episode was $3,400, versus roughly $6,720 for a 14-day stay in a skilled nursing facility.

Project objectives

The objectives of the project for which the K01 grant was awarded are threefold:

  • To explore barriers affecting the initial implementation of HIHR for stroke patients
  • To compare the effectiveness of HIHR to facility-based rehabilitation for improving patients’ function
  • To implement a refined HIHR model and reexamine its implementation and effectiveness

The Cleveland Clinic team also will be examining the impact of the new HIHR paradigm on costs of care. “Post-acute care has become a primary target for cost reduction in the U.S. healthcare system,” Dr. Johnson notes. “Our initial experience with home-based rehabilitation for stroke patients suggests that it may be 30% to 50% less costly than facility-based rehabilitation.”

Advertisement

Quantitative and qualitative outcomes assessed

The researchers anticipate that over a 12-month period, 30 to 40 stroke patients will be enrolled in the HIHR program. The control group, for purposes of comparison, will be similar patients receiving care in inpatient rehabilitation and skilled nursing facilities during the same time period. Both quantitative and qualitative outcomes will be assessed.

“We will talk to a select group of stroke patients and their primary home caregivers and ask about their experiences,” Dr. Johnson explains. “The aim is to better understand what we need to do differently to identify individuals for whom high-intensity home-based rehab is most appropriate.” Lessons learned from the initial stroke model then will be used to improve the HIHR program and potentially broaden its applicability to other types of patients.

Appropriate staffing is key

Reflecting on the challenges of implementing HIHR and advice for other institutions contemplating a similar approach, Dr. Johnson identifies staffing as a major concern.

“Having enough appropriately trained rehabilitation specialists is key,” he says. “For that reason, our leaders in the Center for Connected Care have been very purposeful about hiring therapists with experience treating patients with significant functional deficits. For now, this care model is available only for patients discharged from select Cleveland Clinic hospitals. With the right team and for the right patients, high-intensity home-based rehabilitation can be a high-value substitute for facility-based care. This makes it likely to offer important benefits for the healthcare system.”

Advertisement

Related Articles

two brain scans side by side with a yellow circle on the left scan
March 13, 2026/Neurosciences/Epilepsy

SEEG Linked With More Complete Resection and Greater Seizure Freedom in MOGHE Subtype of Epilepsy

Insights from one of the first studies of invasive monitoring in the rare form of focal cortical dysplasia

histopathology image with pink background and arrow pointing to round cell

New Insights on α-Synuclein Pathology and Clinical Phenotypes in Dementia With Lewy Bodies

The disease’s neuropathologic heterogeneity holds clues to refining diagnosis and prognosis

MRI of the brain against black background

Advanced Neuroimaging and Clinical Perseverance Make Sense of a 68-Year-Old’s Progressive Symptoms

A case study in pairing imaging acumen with subspecialty expertise to yield answers and symptom relief

brain scan with colored dots over a dark gray region
March 3, 2026/Neurosciences/Epilepsy

Decoding the Insula: New Semiological Insights for Localizing Seizure Onset

Guidance from the largest cohort of SEEG-confirmed insular epilepsy patients reported to date

Photo of Dr. Ford
March 2, 2026/Neurosciences/Podcast

Neuroethics Conversations: Guidelines for Care (Podcast)

Ethical guidance provides guardrails so medical advances benefit patients

red blood cells floating in a blood vessel
February 27, 2026/Neurosciences/Cerebrovascular

Factor XIa Inhibition Drives Down Recurrent Stroke Risk Without Rise in Bleeding

OCEANIC-STROKE results represent long-sought advance in secondary stroke prevention

two brightly colored brain scans side by side
February 25, 2026/Neurosciences/Epilepsy

MR Fingerprinting Shows Potential to Reshape FCD Detection and Epileptogenicity Mapping

Two studies from Cleveland Clinic may help advance the technology toward broader clinical use

MRI scan of the side of a human head
February 20, 2026/Neurosciences/Cerebrovascular

Susac Syndrome: Insights on Rare Endotheliopathy From Largest Single-Center Cohort to Date

Distinct MRI signature includes lesions beyond the corpus callosum, features predictive of vision and hearing loss

Ad